• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TRIM47 通过激活 STAT3 信号促进卵巢癌细胞的增殖、迁移和侵袭。

TRIM47 promotes ovarian cancer cell proliferation, migration, and invasion by activating STAT3 signaling.

机构信息

Department of Emergency and Critical Care Medicine, Jinshan Hospital, Fudan University, Shanghai, China.

Department of Obstetrics and Gynecology, Jinshan Hospital, Fudan University, Shanghai, China.

出版信息

Clinics (Sao Paulo). 2022 Oct 23;77:100122. doi: 10.1016/j.clinsp.2022.100122. eCollection 2022.

DOI:10.1016/j.clinsp.2022.100122
PMID:36288633
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9614564/
Abstract

OBJECTIVES

Tripartite Motif 47 (TRIM47) protein plays a prominent role in many cancers. This study aimed to investigate the biological roles of TRIM47 in ovarian cancer.

METHODS

TRIM47 was knocked down and overexpressed in ovarian cancer cell lines SKOV3 and OVCAR3, and the effects on proliferation, clone formation, apoptosis, invasion, and growth of xenograft tumors in nude mice were determined. The expression levels of the selected candidates were tested by western blotting and quantitative real-time PCR.

RESULTS

TRIM47 knockdown suppressed proliferation and encourages apoptosis of ovarian cancer cells. Similarly, TRIM47 knockdown suppressed ovarian cancer cell invasion, migration, and epithelial-mesenchymal transition. Ovarian cancer cell xenograft assays demonstrated that TRIM47 knockdown significantly inhibited tumor growth. Mechanistically, TRIM47 knockdown suppressed STAT3 phosphorylation and the expression of several downstream genes, including MCL-1, MMP2, and c-MYC. Silencing of STAT3 partially prevented TRIM47-induced tumor cell proliferation and invasion.

CONCLUSION

The present study's findings demonstrate that by activating STAT3 signaling, TRIM47 functions as an oncogene in ovarian cancer. TRIM47, therefore, appears to be a potential target for ovarian cancer prevention and/or therapy.

摘要

目的

三基序蛋白 47(TRIM47)蛋白在许多癌症中发挥着重要作用。本研究旨在探讨 TRIM47 在卵巢癌中的生物学作用。

方法

在卵巢癌细胞系 SKOV3 和 OVCAR3 中敲低和过表达 TRIM47,检测其对细胞增殖、克隆形成、凋亡、侵袭和裸鼠移植瘤生长的影响。通过 Western blot 和定量实时 PCR 检测候选物的表达水平。

结果

TRIM47 敲低抑制卵巢癌细胞的增殖并促进其凋亡。同样,TRIM47 敲低抑制卵巢癌细胞的侵袭、迁移和上皮间质转化。卵巢癌细胞移植瘤实验表明,TRIM47 敲低显著抑制肿瘤生长。机制上,TRIM47 敲低抑制 STAT3 磷酸化和几个下游基因的表达,包括 MCL-1、MMP2 和 c-MYC。STAT3 的沉默部分阻止了 TRIM47 诱导的肿瘤细胞增殖和侵袭。

结论

本研究结果表明,TRIM47 通过激活 STAT3 信号通路在卵巢癌中发挥癌基因的作用。因此,TRIM47 似乎是预防和/或治疗卵巢癌的潜在靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1b8/9614564/7becd0e81001/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1b8/9614564/bc6b9758e97a/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1b8/9614564/4c3340f5f49d/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1b8/9614564/2dba74958b07/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1b8/9614564/d5c24db44099/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1b8/9614564/a05d327edc18/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1b8/9614564/7becd0e81001/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1b8/9614564/bc6b9758e97a/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1b8/9614564/4c3340f5f49d/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1b8/9614564/2dba74958b07/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1b8/9614564/d5c24db44099/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1b8/9614564/a05d327edc18/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1b8/9614564/7becd0e81001/gr6.jpg

相似文献

1
TRIM47 promotes ovarian cancer cell proliferation, migration, and invasion by activating STAT3 signaling.TRIM47 通过激活 STAT3 信号促进卵巢癌细胞的增殖、迁移和侵袭。
Clinics (Sao Paulo). 2022 Oct 23;77:100122. doi: 10.1016/j.clinsp.2022.100122. eCollection 2022.
2
Knockdown of TRIM47 inhibits breast cancer tumorigenesis and progression through the inactivation of PI3K/Akt pathway.敲低 TRIM47 通过抑制 PI3K/Akt 通路抑制乳腺癌的发生发展。
Chem Biol Interact. 2020 Feb 1;317:108960. doi: 10.1016/j.cbi.2020.108960. Epub 2020 Jan 22.
3
Knockdown of TRIM47 inhibits glioma cell proliferation, migration and invasion through the inactivation of Wnt/β-catenin pathway.敲低TRIM47通过Wnt/β-连环蛋白信号通路失活抑制胶质瘤细胞增殖、迁移和侵袭。
Mol Cell Probes. 2020 Oct;53:101623. doi: 10.1016/j.mcp.2020.101623. Epub 2020 Jun 27.
4
TRIM47 is up-regulated in colorectal cancer, promoting ubiquitination and degradation of SMAD4.TRIM47 在结直肠癌中上调,促进 SMAD4 的泛素化和降解。
J Exp Clin Cancer Res. 2019 Apr 12;38(1):159. doi: 10.1186/s13046-019-1143-x.
5
TRIM47 overexpression is a poor prognostic factor and contributes to carcinogenesis in non-small cell lung carcinoma.TRIM47过表达是一个不良预后因素,并且在非小细胞肺癌的致癌过程中起作用。
Oncotarget. 2017 Apr 4;8(14):22730-22740. doi: 10.18632/oncotarget.15188.
6
TRIM47 silencing inhibits the malignant biological behaviors of prostate cancer cells by regulating MDM2/p53 signaling.沉默 TRIM47 通过调节 MDM2/p53 信号通路抑制前列腺癌细胞的恶性生物学行为。
Cell Biochem Biophys. 2024 Jun;82(2):1567-1578. doi: 10.1007/s12013-024-01308-7. Epub 2024 May 27.
7
TRIM47 inhibits cisplatin chemosensitivity and endoplasmic reticulum stress-induced apoptosis of ovarian cancer cells.TRIM47 抑制顺铂化疗敏感性和内质网应激诱导的卵巢癌细胞凋亡。
Mol Cell Probes. 2024 Oct;77:101978. doi: 10.1016/j.mcp.2024.101978. Epub 2024 Aug 3.
8
Upregulated Tripartite Motif 47 Could Facilitate Glioma Cell Proliferation and Metastasis as a Tumorigenesis Promoter.上调的三联基序蛋白47作为肿瘤发生促进因子可促进胶质瘤细胞增殖和转移。
Comput Math Methods Med. 2021 Mar 25;2021:5594973. doi: 10.1155/2021/5594973. eCollection 2021.
9
Down-regulation of PADI2 prevents proliferation and epithelial-mesenchymal transition in ovarian cancer through inhibiting JAK2/STAT3 pathway in vitro and in vivo, alone or in combination with Olaparib.PADI2的下调通过在体外和体内单独或与奥拉帕尼联合抑制JAK2/STAT3信号通路来阻止卵巢癌的增殖和上皮-间质转化。
J Transl Med. 2020 Sep 20;18(1):357. doi: 10.1186/s12967-020-02528-0.
10
lncRNA MIAT Regulates Cell Growth, Migration, and Invasion Through Sponging miR-150-5p in Ovarian Cancer.长链非编码 RNA MIAT 通过海绵吸附 miR-150-5p 调控卵巢癌细胞的生长、迁移和侵袭。
Cancer Biother Radiopharm. 2020 Nov;35(9):650-660. doi: 10.1089/cbr.2019.3259. Epub 2020 Mar 18.

引用本文的文献

1
Enhanced Expression of TRIM46 in Ovarian Cancer Cells Induced by Tumor-Associated Macrophages Promotes Invasion via the Wnt/β-Catenin Pathway.肿瘤相关巨噬细胞诱导的卵巢癌细胞中TRIM46表达增强通过Wnt/β-连环蛋白途径促进侵袭。
Cells. 2025 Feb 2;14(3):214. doi: 10.3390/cells14030214.
2
TRIM47 promotes head and neck squamous cell carcinoma malignant progression by degrading XAF1 through ubiquitination.TRIM47 通过泛素化降解 XAF1 促进头颈部鳞状细胞癌的恶性进展。
iScience. 2024 Dec 13;28(1):111590. doi: 10.1016/j.isci.2024.111590. eCollection 2025 Jan 17.
3
Multifaceted role of in health and disease.

本文引用的文献

1
GBAS Regulates the Proliferation and Metastasis of Ovarian Cancer Cells by Combining with eEF1A1.GBAS 通过与 eEF1A1 结合来调节卵巢癌细胞的增殖和转移。
Oncologist. 2022 Feb 3;27(1):e64-e75. doi: 10.1093/oncolo/oyab015.
2
TRIM47 activates NF-κB signaling via PKC-ε/PKD3 stabilization and contributes to endocrine therapy resistance in breast cancer.TRIM47通过稳定PKC-ε/PKD3激活NF-κB信号通路,并促进乳腺癌的内分泌治疗耐药性。
Proc Natl Acad Sci U S A. 2021 Aug 31;118(35). doi: 10.1073/pnas.2100784118.
3
The translational values of TRIM family in pan-cancers: From functions and mechanisms to clinics.
[此处原文不完整,缺少具体所指内容]在健康与疾病中的多方面作用。
MedComm (2020). 2024 Nov 11;5(11):e790. doi: 10.1002/mco2.790. eCollection 2024 Nov.
4
TRIM47 is a prognostic biomarker for gallbladder cancer and promotes tumor progression through regulating K63-linked ubiquitination of PARP1.TRIM47是胆囊癌的一种预后生物标志物,通过调节PARP1的K63连接泛素化促进肿瘤进展。
Transl Oncol. 2025 Jan;51:102164. doi: 10.1016/j.tranon.2024.102164. Epub 2024 Nov 2.
5
TRIM47 promotes the Warburg effect and reduces ferroptosis in prostate cancer by FBP1 and FOXO1.TRIM47通过FBP1和FOXO1促进前列腺癌的瓦伯格效应并减少铁死亡。
Transl Androl Urol. 2024 Sep 30;13(9):1991-2004. doi: 10.21037/tau-23-605. Epub 2024 Sep 26.
6
The Role of STATs in Ovarian Cancer: Exploring Their Potential for Therapy.信号转导和转录激活因子在卵巢癌中的作用:探索其治疗潜力
Cancers (Basel). 2023 Apr 26;15(9):2485. doi: 10.3390/cancers15092485.
TRIM 家族在泛癌症中的翻译价值:从功能和机制到临床应用。
Pharmacol Ther. 2021 Nov;227:107881. doi: 10.1016/j.pharmthera.2021.107881. Epub 2021 Apr 28.
4
TRIM47 promotes malignant progression of renal cell carcinoma by degrading P53 through ubiquitination.TRIM47通过泛素化降解P53促进肾细胞癌的恶性进展。
Cancer Cell Int. 2021 Feb 23;21(1):129. doi: 10.1186/s12935-021-01831-0.
5
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
6
TRIM47 accelerates aerobic glycolysis and tumor progression through regulating ubiquitination of FBP1 in pancreatic cancer.TRIM47 通过调节 FBP1 的泛素化促进胰腺癌的有氧糖酵解和肿瘤进展。
Pharmacol Res. 2021 Apr;166:105429. doi: 10.1016/j.phrs.2021.105429. Epub 2021 Jan 30.
7
Activation of STAT3 and STAT5 Signaling in Epithelial Ovarian Cancer Progression: Mechanism and Therapeutic Opportunity.STAT3和STAT5信号通路激活在上皮性卵巢癌进展中的作用:机制与治疗机遇
Cancers (Basel). 2019 Dec 19;12(1):24. doi: 10.3390/cancers12010024.
8
Multi-omics profiling reveals key signaling pathways in ovarian cancer controlled by STAT3.多组学分析揭示了 STAT3 调控的卵巢癌关键信号通路。
Theranostics. 2019 Jul 28;9(19):5478-5496. doi: 10.7150/thno.33444. eCollection 2019.
9
TRIM50 acts as a novel Src suppressor and inhibits ovarian cancer progression.TRIM50 作为一种新型的Src 抑制因子,抑制卵巢癌的进展。
Biochim Biophys Acta Mol Cell Res. 2019 Sep;1866(9):1412-1420. doi: 10.1016/j.bbamcr.2019.06.002. Epub 2019 Jun 6.
10
TRIM47 is up-regulated in colorectal cancer, promoting ubiquitination and degradation of SMAD4.TRIM47 在结直肠癌中上调,促进 SMAD4 的泛素化和降解。
J Exp Clin Cancer Res. 2019 Apr 12;38(1):159. doi: 10.1186/s13046-019-1143-x.